Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint Inhibitors.

Formica, Vincenzo; Morelli, Cristina; Patrikidou, Anna; Murias, Carmen; Butt, Sabeeh; Nardecchia, Antonella; Lucchetti, Jessica; Renzi, Nicola; Shiu, Kai-Keen; Roselli, Mario; Arkenau, Hendrik-Tobias

Formica, Vincenzo; Morelli, Cristina; Patrikidou, Anna; Murias, Carmen; Butt, Sabeeh; Nardecchia, Antonella; Lucchetti, Jessica; Renzi, Nicola; Shiu, Kai-Keen; Roselli, Mario; Arkenau, Hendrik-Tobias.

Afiliação

Formica V; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Viale Oxford, 81, 00133, Rome, Italy. v.formica1@gmail.com.
Morelli C; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Viale Oxford, 81, 00133, Rome, Italy.
Patrikidou A; Medical Oncology, Sarah Cannon Research Institute UK, London, UK.
Murias C; Medical Oncology, Sarah Cannon Research Institute UK, London, UK.
Butt S; Medical Oncology, Sarah Cannon Research Institute UK, London, UK.
Nardecchia A; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Viale Oxford, 81, 00133, Rome, Italy.
Lucchetti J; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Viale Oxford, 81, 00133, Rome, Italy.
Renzi N; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Viale Oxford, 81, 00133, Rome, Italy.
Shiu KK; Department of Oncology, University College Hospital, 235 Euston Road, London, NW1 2BU, UK.
Roselli M; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Viale Oxford, 81, 00133, Rome, Italy.
Arkenau HT; Medical Oncology, Sarah Cannon Research Institute UK, London, UK.

Target Oncol ; 15(3): 327-336, 2020 06.

Article em En | MEDLINE | ID: mdl-32449030

Assuntos

Inibidores de Checkpoint Imunológico/uso terapêutico; Inflamação/metabolismo; Receptor de Morte Celular Programada 1/uso terapêutico; Neoplasias Gástricas/tratamento farmacológico; Adulto; Idoso; Idoso de 80 Anos ou mais; Feminino; Humanos; Inibidores de Checkpoint Imunológico/farmacologia; Masculino; Pessoa de Meia-Idade; Metástase Neoplásica; Prognóstico; Estudos Retrospectivos; Neoplasias Gástricas/mortalidade; Análise de Sobrevida; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico / Inflamação Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google